Skip to Content


Active Substance: sildenafil
Common Name: sildenafil
ATC Code: G04BE03
Marketing Authorisation Holder: Pfizer Limited
Active Substance: sildenafil
Status: Withdrawn
Authorisation Date: 1998-09-15
Therapeutic Area: Erectile Dysfunction
Pharmacotherapeutic Group: Urologicals

Therapeutic Indication

Treatment of men with erectile dysfunction, which is the inability to achieve or maintain a penile
erection sufficient for satisfactory sexual performance.
In order for Patrex to be effective, sexual stimulation is required.
PATREX is not indicated for use by women.

The marketing authorisation for Patrex has not been renewed by the marketing authorisation holder and is now withdrawn.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.